Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.090 AUD
−35.98 M AUD
3.75 M AUD
319.93 M
About 4DMEDICAL LIMITED
Sector
Industry
CEO
Andreas Fouras
Website
Headquarters
Carlton
Founded
2012
ISIN
AU0000095416
FIGI
BBG00VSFDKL5
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4DX is 0.460 AUD — it has increased by 3.37% in the past 24 hours. Watch 4DMEDICAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange 4DMEDICAL LIMITED stocks are traded under the ticker 4DX.
4DX stock has risen by 2.22% compared to the previous week, the month change is a −1.08% fall, over the last year 4DMEDICAL LIMITED has showed a −35.21% decrease.
We've gathered analysts' opinions on 4DMEDICAL LIMITED future price: according to them, 4DX price has a max estimate of 1.10 AUD and a min estimate of 1.10 AUD. Watch 4DX chart and read a more detailed 4DMEDICAL LIMITED stock forecast: see what analysts think of 4DMEDICAL LIMITED and suggest that you do with its stocks.
4DX stock is 5.49% volatile and has beta coefficient of 1.66. Track 4DMEDICAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is 4DMEDICAL LIMITED there?
Today 4DMEDICAL LIMITED has the market capitalization of 189.34 M, it has decreased by −1.02% over the last week.
Yes, you can track 4DMEDICAL LIMITED financials in yearly and quarterly reports right on TradingView.
4DMEDICAL LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
4DX net income for the last half-year is −20.37 M AUD, while the previous report showed −15.61 M AUD of net income which accounts for −30.54% change. Track more 4DMEDICAL LIMITED financial stats to get the full picture.
No, 4DX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 145.00 employees. See our rating of the largest employees — is 4DMEDICAL LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4DMEDICAL LIMITED EBITDA is −44.16 M AUD, and current EBITDA margin is −1.18 K%. See more stats in 4DMEDICAL LIMITED financial statements.
Like other stocks, 4DX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4DMEDICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 4DMEDICAL LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 4DMEDICAL LIMITED stock shows the sell signal. See more of 4DMEDICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.